Xiao-hua Zeng
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Efficacy and Safety of Neoadjuvant TQB2102 in Locally Advanced or Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Randomized, Open-Label, Multicenter, Phase II Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 25, 2025
Spatially interpretable artificial intelligence framework to tailored neoadjuvant dual HER2 blockade in HER2-positive breast cancer.
Journal: Signal transduction and targeted therapy
Published: October 19, 2025
Optimizing intraoperative radiotherapy as a tumor bed boost with whole-breast irradiation in breast cancer.
Journal: World journal of surgical oncology
Published: May 14, 2025
Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2- breast cancer: The LINUXtrial.
Journal: Cancer cell
Published: March 08, 2025
Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial.
Journal: BMJ (Clinical research ed.)
Published: October 23, 2024
miR-520b Inhibits IGF-1R to Increase Doxorubicin Sensitivity and Promote Cell Apoptosis in Breast Cancer.
Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Published: October 29, 2020
Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical Trial.
Journal: JAMA oncology
Published: August 14, 2020
miR-520b Promotes Breast Cancer Stemness Through Hippo/YAP Signaling Pathway.
Journal: OncoTargets and therapy
Published: October 30, 2019
Clinicopathologic Factors Related to the Histological Tumor Grade of Breast Cancer in Western China: An Epidemiological Multicenter Study of 8619 Female Patients.
Journal: Translational oncology
Published: April 25, 2018
Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study.
Journal: Breast cancer research and treatment
Published: November 28, 2017
Absence of multiple atypical chemokine binders (ACBs) and the presence of VEGF and MMP-9 predict axillary lymph node metastasis in early breast carcinomas.
Journal: Medical oncology (Northwood, London, England)
Published: June 08, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026